<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm - Shantsila, E - 2016 | Cochrane Library</title> <meta content="Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm - Shantsila, E - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003333.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm - Shantsila, E - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003333.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003333.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm" name="citation_title"/> <meta content="Eduard Shantsila" name="citation_author"/> <meta content="City Hospital, Sandwell and West Birmingham Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Gregory YH Lip" name="citation_author"/> <meta content="University of Liverpool" name="citation_author_institution"/> <meta content="Gregory.Lip@liverpool.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD003333.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/09/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003333.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003333.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003333.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [*therapeutic use]; Heart Failure [*complications, mortality]; Platelet Aggregation Inhibitors [*therapeutic use]; Randomized Controlled Trials as Topic; Thromboembolism [*drug therapy, etiology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003333.pub3&amp;doi=10.1002/14651858.CD003333.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xx9QLps0";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003333\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003333\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ko","ms","hr","fr","pl","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003333.pub3",title:"Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm",firstPublishedDate:"Sep 15, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003333.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003333.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003333.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003333.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003333.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003333.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003333.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003333.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003333.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003333.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3778 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003333.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-sec-0075"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-sec-0072"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/appendices#CD003333-sec-0080"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/table_n/CD003333StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/table_n/CD003333StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information#CD003333-cr-0002">Eduard Shantsila</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information#CD003333-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Gregory YH Lip</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information/en#CD003333-sec-0107">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 September 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003333.pub3">https://doi.org/10.1002/14651858.CD003333.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003333-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003333-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003333-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003333-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003333-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD003333-abs-0002">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003333-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003333-abs-0001" lang="en"> <section id="CD003333-sec-0001"> <h3 class="title" id="CD003333-sec-0001">Background</h3> <p>Morbidity in patients with chronic heart failure is high, and this predisposes them to thrombotic complications, including stroke and thromboembolism, which in turn contribute to high mortality. Oral anticoagulants (e.g. warfarin) and antiplatelet agents (e.g. aspirin) are the principle oral antithrombotic agents. Many heart failure patients with sinus rhythm take aspirin because coronary artery disease is the leading cause of heart failure. Oral anticoagulants have become a standard in the management of heart failure with atrial fibrillation. However, a question remains regarding the appropriateness of oral anticoagulants in heart failure with sinus rhythm. This update of a review previously published in 2012 aims to address this question. </p> </section> <section id="CD003333-sec-0002"> <h3 class="title" id="CD003333-sec-0002">Objectives</h3> <p>To assess the effects of oral anticoagulant therapy versus antiplatelet agents for all‐cause mortality, non‐fatal cardiovascular events and risk of major bleeding in adults with heart failure (either with reduced or preserved ejection fraction) who are in sinus rhythm. </p> </section> <section id="CD003333-sec-0003"> <h3 class="title" id="CD003333-sec-0003">Search methods</h3> <p>We updated the searches in September 2015 on CENTRAL (<i>The Cochrane Library</i>), MEDLINE and Embase. We searched reference lists of papers and abstracts from cardiology meetings and contacted study authors for further information. We did not apply any language restrictions. Additionally, we searched two clinical trials registers: ClinicalTrials.gov (<a href="http://www.ClinicalTrials.gov" target="_blank">www.ClinicalTrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Search Portal <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) (searched in July 2016). </p> </section> <section id="CD003333-sec-0004"> <h3 class="title" id="CD003333-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials comparing antiplatelet therapy versus oral anticoagulation in adults with chronic heart failure in sinus rhythm. Treatment had to last at least one month. We compared orally administered antiplatelet agents (aspirin, ticlopidine, clopidogrel, prasugrel, ticagrelor, dipyridamole) versus anticoagulant agents (coumarins, warfarin, non‐vitamin K oral anticoagulants). </p> </section> <section id="CD003333-sec-0005"> <h3 class="title" id="CD003333-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trials for inclusion and assessed the risks and benefits of antithrombotic versus antiplatelet therapy using relative measures of effects, such as risk ratios (RR), accompanied with 95% confidence intervals (CI). The data extracted included data relating to the study design, patient characteristics, study eligibility, quality, and outcomes. We used GRADE criteria to assess the quality of the evidence. </p> </section> <section id="CD003333-sec-0006"> <h3 class="title" id="CD003333-sec-0006">Main results</h3> <p>This update identified one additional study for inclusion, adding data for 2305 participants. This addition more than doubled the overall number of patients eligible for the review. In total, we included four randomised controlled trials (RCTs) with a total of 4187 eligible participants. All studies compared warfarin with aspirin. One RCT additionally compared warfarin with clopidogrel. All included RCTs studied patients with heart failure with reduced ejection fraction. </p> <p>Analysis of all outcomes for warfarin versus aspirin was based on 3663 patients from four RCTs. All‐cause mortality was similar for warfarin and aspirin (RR 1.00, 95% CI 0.89 to 1.13; 4 studies; 3663 participants; moderate quality evidence). Oral anticoagulation was associated with a reduction in non‐fatal cardiovascular events, which included non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism (RR 0.79, 95% CI 0.63 to 1.00; 4 studies; 3663 participants; moderate quality evidence). The rate of major bleeding events was twice as high in the warfarin groups (RR 2.00, 95% CI 1.44 to 2.78; 4 studies; 3663 participants; moderate quality evidence). We generally considered the risk of bias of the included studies to be low. </p> <p>Analysis of warfarin versus clopidogrel was based on a single RCT (N = 1064). All‐cause mortality was similar for warfarin and clopidogrel (RR 0.93, 95% CI 0.72 to 1.21; 1 study; 1064 participants; low quality evidence). There were similar rates of non‐fatal cardiovascular events (RR 0.85, 95% CI 0.50 to 1.45; 1 study; 1064 participants; low quality evidence). The rate of major bleeding events was 2.5 times higher in the warfarin group (RR 2.47, 95% CI 1.24 to 4.91; 1 study; 1064 participants; low quality evidence). Risk of bias for this study can be summarised as low. </p> </section> <section id="CD003333-sec-0007"> <h3 class="title" id="CD003333-sec-0007">Authors' conclusions</h3> <p>There is evidence from RCTs to suggest that neither oral anticoagulation with warfarin or platelet inhibition with aspirin is better for mortality in systolic heart failure with sinus rhythm (high quality of the evidence for all‐cause mortality and moderate quality of the evidence for non‐fatal cardiovascular events and major bleeding events). Treatment with warfarin was associated with a 20% reduction in non‐fatal cardiovascular events but a twofold higher risk of major bleeding complications (high quality of the evidence). We saw a similar pattern of results for the warfarin versus clopidogrel comparison (low quality of the evidence). At present, there are no data on the role of oral anticoagulation versus antiplatelet agents in heart failure with preserved ejection fraction with sinus rhythm. Also, there were no data from RCTs on the utility of non‐vitamin K antagonist oral anticoagulants compared to antiplatelet agents in heart failure with sinus rhythm. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003333-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003333-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003333-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003333-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003333-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD003333-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ko#CD003333-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003333-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD003333-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003333-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003333-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003333-abs-0005" lang="en"> <h3>Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm </h3> <p><b>Background</b> </p> <p>Blood clots can be formed by clotting proteins (coagulation factors) and sticky blood cells (platelets). Oral anticoagulants such as warfarin are drugs that can prevent clot formation by blocking the clotting proteins. Other drugs, like aspirin, can also reduce clotting by blocking the platelets. Warfarin is better than aspirin in patients with heart failure who have abnormal heart rhythm (atrial fibrillation). Aspirin is known to be helpful in patients with heart failure with normal (sinus) rhythm, whose heart arteries are narrowed. This condition is a common cause of heart failure, so doctors often advise patients with a normal rhythm to take aspirin. Arguably, people with heart failure with a normal rhythm are at increased risk of clotting due to slower blood flow in the heart, similarly to people with an abnormal rhythm. Also, blood clots (thromboembolism) in the lungs, legs and brain (ischaemic stroke) lead to disability and death of patients with heart failure. Several studies have tried to find out whether all heart failure patients should receive oral anticoagulants, but the debate is still open. </p> <p><b>Study characteristics</b> </p> <p>This is an update of an earlier review. The evidence is current to September 2015. We only identified one new study with 2305 participants. In total, we analysed four randomised controlled studies with 4187 participants. </p> <p><b>Key results</b> </p> <p>The comparison of warfarin with aspirin was based on a large number of patients from four high‐quality studies. The analysis showed an almost identical risk of death with both drugs. There was not enough evidence to prove benefits of warfarin over aspirin to reduce the possibility of clotting complications, such as a heart attack or stroke. However, patients receiving warfarin experienced serious bleeding twice as often as those taking aspirin. A comparison of warfarin with another antiplatelet drug, clopidogrel, was based on a single medium size study, and it showed similar results: no difference in occurrence of death or clotting complications, but a higher chance of developing of a serious bleed. </p> <p><b>Conclusions</b> </p> <p>There is currently no evidence to suggest advantages of warfarin over antiplatelet drugs in heart failure with a normal rhythm. Moreover, treatment with warfarin leads to more bleeding events than aspirin or clopidogrel. It is unlikely that further studies will change these conclusions unless new, more effective and safe drugs become available. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003333-sec-0075" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003333-sec-0075"></div> <h3 class="title" id="CD003333-sec-0076">Implications for practice</h3> <section id="CD003333-sec-0076"> <p>There is moderate quality evidence demonstrating no difference in all‐cause mortality between warfarin and aspirin in patients with heart failure in sinus rhythm. Warfarin was associated with a slightly lower risk of non‐fatal cardiovascular events but a higher risk of major bleeding complications (moderate quality of the evidence). We saw a similar pattern of results for the warfarin versus clopidogrel comparison (low quality evidence). At the time of writing, there were no data on the role of oral anticoagulants versus antiplatelet agents in heart failure with preserved ejection fraction with sinus rhythm. Likewise, there were no data from RCTs on the utility of non‐vitamin K oral anticoagulants compared to antiplatelet agents in heart failure with sinus rhythm. </p> </section> <h3 class="title" id="CD003333-sec-0077">Implications for research</h3> <section id="CD003333-sec-0077"> <p>Current evidence is based on four randomised controlled trials (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>, <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>), and further similar studies are unlikely to change the conclusions regarding comparisons of warfarin with aspirin. Although comparison of warfarin with clopidogrel is only based on a single, medium‐size study, it generally agrees with the conclusions of the aspirin studies, and new studies are unlikely to lead to new clinically relevant conclusions. </p> <p>Several non‐vitamin K antagonist oral anticoagulants have now been approved for clinical practice. They show good efficacy and a favourable safety profile in other clinical settings, including heart failure with arterial fibrillation. Future trials should establish the potential utility of these agents in patients with heart failure with sinus rhythm. </p> <p>The role of antithrombotic agents in heart failure with preserved ejection fraction remains unclear. It would be important to obtain contemporary data on thrombotic risk specific to this condition, and if the risk is confirmed, high‐quality RCTs would be necessary to establish optimal management of such patients. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003333-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003333-sec-0029"></div> <div class="table" id="CD003333-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: warfarin versus aspirin for heart failure with sinus rhythm</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Warfarin versus aspirin for heart failure with sinus rhythm</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: patients with heart failure with sinus rhythm </p> <p><b>Settings</b>: outpatient clinics </p> <p><b>Intervention</b>: warfarin </p> <p><b>Comparison</b>: aspirin </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)<sup>a</sup> </b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Aspirin</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Warfarin</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Mean follow‐up: 18.5‐42 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b><br/> (195 to 247) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> (0.89 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3663<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)</b> </p> <p>Mean follow‐up: 18.5‐42 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>66 per 1000</b><br/> (52 to 83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.79</b> (0.63 to 1.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3663<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major bleeding events</b> </p> <p>Mean follow‐up: 18.5‐42 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b><br/> (40 to 78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.00</b> (1.44 to 2.78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3663<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>All results are presented for the whole population analyses. The assumed risk is provided based on the aspirin group as aspirin is often used in patients with heart failure with sinus rhythm due to background ischaemic heart disease.<br/> <sup>b</sup>Downgraded due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003333-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: warfarin versus clopidogrel for heart failure with sinus rhythm</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Warfarin versus clopidogrel for heart failure with sinus rhythm</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: patients with heart failure with sinus rhythm </p> <p><b>Settings</b>: oupatient clinics </p> <p><b>Intervention</b>: warfarin </p> <p><b>Comparison</b>: clopidogrel </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Clopidogrel</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Warfarin</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Mean follow‐up: 1.9 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>183 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>170 per 1000</b><br/> (132 to 221) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.93</b> (0.72 to 1.21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1064<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)</b> </p> <p>Mean follow‐up: 1.9 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b><br/> (27 to 78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b> (0.50 to 1.45) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1064<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major bleeding events</b> </p> <p>Mean follow‐up: 1.9 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b><br/> (25 to 98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.47</b> (1.24 to 4.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1064<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003333-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003333-sec-0030"></div> <section id="CD003333-sec-0031"> <h3 class="title" id="CD003333-sec-0031">Description of the condition</h3> <p>Chronic heart failure is a major clinical and social problem and a significant cause of morbidity, with almost 60% five‐year mortality despite modern treatments (<a href="./references#CD003333-bbs2-0034" title="StewartS , EkmanI , EkmanT , OdénA , RosengrenA . Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circulation: Cardiovascular Quality and Outcomes2010;6:573‐80. ">Stewart 2010</a>). Heart failure poses an increased risk of thrombotic complications, which occur in a third of patients with the disease (<a href="./references#CD003333-bbs2-0025" title="LipGY , PiotrponikowskiP , AndreottiF , AnkerSD , FilippatosG , HommaS , et al. Heart Failure Association (EHFA) of the European Society of Cardiology (ESC) and the ESC Working Group onThrombosis. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Thrombosis and Haemostasis2012;108:1009‐22. ">Lip 2012</a>). Mild to moderate heart failure is associated with an annual stroke risk of approximately 1.5% (<a href="./references#CD003333-bbs2-0037" title="WittBJ , GamiAS , BallmanKV , BrownRDJr , MeverdenRA , JacobsenSJ , et al. The incidence of ischemic stroke in chronic heart failure: a meta‐analysis. Journal of Cardiac Failure2007;6:489‐96. ">Witt 2007</a>), compared to less than 0.5% in the general population, while the annual risk of stroke increases to almost 4% in severe heart failure (<a href="./references#CD003333-bbs2-0027" title="PackerM , CarverJR , RodehefferRJ , IvanhoeRJ , DiBiancoR , ZeldisSM , et al. Effects of oral milrinone on mortality in severe chronic heart failure. New England Journal of Medicine1991;325:1468‐75. ">Packer 1991</a>). Indeed, the SAVE study reported an inverse relationship between stroke risk and the left ventricular ejection fraction (LVEF), with an 18% increase in stroke risk for every 5% reduction in LVEF in severe heart failure (<a href="./references#CD003333-bbs2-0010" title="LohE , SuttonMS , WunCC , RouleauJL , FlakerGC , GottliebSS , et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. New England Journal of Medicine1997;336:251‐7. ">SAVE 1997</a>). People with heart failure are also prone to developing venous thromboembolism (<a href="./references#CD003333-bbs2-0022" title="KhouryH , WelnerS , KubinM , FolkertsK , HaasS . Disease burden and unmet needs for prevention of venous thromboembolism in medically ill patients in Europe show underutilisation of preventive therapies. Thrombosis and Haemostasis2011;106:600‐8. ">Khoury 2011</a>; <a href="./references#CD003333-bbs2-0028" title="PiazzaG , GoldhaberSZ , LessardDM , GoldbergRJ , EmeryC , SpencerFA . Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. American Journal of Medicine2011;124:252‐9. ">Piazza 2011</a>). Pulmonary embolism and peripheral arterial embolism clearly contribute to the high morbidity in heart failure (<a href="./references#CD003333-bbs2-0015" title="AlbertsVP , BosMJ , KoudstaalPJ , HofmanA , WittemanJC , StrickerBH , BretelerMM . Heart failure and the risk of stroke: the Rotterdam Study. European Journal of Epidemiology2010;25:807‐12. ">Alberts 2010</a>; <a href="./references#CD003333-bbs2-0037" title="WittBJ , GamiAS , BallmanKV , BrownRDJr , MeverdenRA , JacobsenSJ , et al. The incidence of ischemic stroke in chronic heart failure: a meta‐analysis. Journal of Cardiac Failure2007;6:489‐96. ">Witt 2007</a>). Multiple factors predispose patients with heart failure to prothrombotic risk, including diastolic dysfunction, blood flow congestion and a hypercoagulable shift in pro‐ versus haemostatic factor balance (<a href="./references#CD003333-bbs2-0030" title="ShantsilaE , LipGY . Preventing thrombosis to improve outcomes in heart failure patients. Progress in Cardiovascular Diseases2016;58:386‐92. ">Shantsila 2016</a>). For these reasons, patients with heart failure are expected to benefit from antithrombotic therapy, and it is essential to have evidence to support the best treatment options for prevention of thrombotic complications. </p> </section> <section id="CD003333-sec-0032"> <h3 class="title" id="CD003333-sec-0032">Description of the intervention</h3> <p>All heart failure patients who have atrial fibrillation have a CHA<sub>2</sub>DS<sub>2</sub>‐VASc score (a measure of stroke risk for patients with atrial fibrillation) of 1 or more and benefit from oral anticoagulation according to the current guidelines (<a href="./references#CD003333-bbs2-0019" title="CammAJ , LipGY , DeCaterinaR , SavelievaI , AtarD , HohnloserSH , et al. ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal2012;33:2719‐47. ">Camm 2012</a>). Choice of an antithrombotic agent in heart failure patients with sinus rhythm is more controversial, but antiplatelet therapy is common. Its use is based on its general efficacy as an antithrombotic agent, as it has been shown to reduce the incidence of myocardial infarction and death in men and women over the age of 50, in patients with unstable angina and myocardial infarction, and in patients with atherosclerotic cerebrovascular disease (<a href="./references#CD003333-bbs2-0016" title="Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy ‐ I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81‐106. ">APT Collab I 1994</a>; <a href="./references#CD003333-bbs2-0018" title="Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta‐analysis of individual participant data from randomised trials. Lancet2009;373(9678):1849‐60. ">ATT 2009</a>), whilst the administration of aspirin improves the patency rates of saphenous‐vein aorto‐coronary bypass grafts (<a href="./references#CD003333-bbs2-0016" title="Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy ‐ I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81‐106. ">APT Collab I 1994</a>; <a href="./references#CD003333-bbs2-0018" title="Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta‐analysis of individual participant data from randomised trials. Lancet2009;373(9678):1849‐60. ">ATT 2009</a>; <a href="./references#CD003333-bbs2-0033" title="SteinPD , DalenJE , GoldmanS , TherouxP . Antithrombotic therapy in patients with saphenous vein and internal mammaryartery bypass grafts. Chest1998;114(5 Suppl):658S‐65S. ">Stein 1998</a>). Aspirin also reduces the incidence of stroke and death in patients with recurrent episodes of cerebral ischaemia (<a href="./references#CD003333-bbs2-0035" title="SzePC , ReitmanD , PincusMM , SacksHS , ChalmersTC . Antiplatelet agents in the secondary prevention of stroke: meta‐analysis of the randomized control trials. Stroke1988;19:436‐42. ">Sze 1988</a>). Given that ischaemic cardiomyopathy is a major aetiological factor of heart failure, clinicians routinely use aspirin. Furthermore, research has shown aspirin to be moderately effective in reducing venous thrombosis and thromboembolism in patients undergoing hip surgery and possibly in preventing these occurrences in general surgical patients (<a href="./references#CD003333-bbs2-0016" title="Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy ‐ I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81‐106. ">APT Collab I 1994</a>).<br/> <br/> Investigators have also studied antiplatelet agents such as dipyridamole and clopidogrel in cardiovascular disease. Studies have shown that dipyridamole reduces the incidence of thromboembolism when added to warfarin in high‐risk patients with prosthetic heart valves (<a href="./references#CD003333-bbs2-0016" title="Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy ‐ I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81‐106. ">APT Collab I 1994</a>; <a href="./references#CD003333-bbs2-0033" title="SteinPD , DalenJE , GoldmanS , TherouxP . Antithrombotic therapy in patients with saphenous vein and internal mammaryartery bypass grafts. Chest1998;114(5 Suppl):658S‐65S. ">Stein 1998</a>), and others have reported that it reduces the risk of stroke when added to aspirin in patients with a history of cerebrovascular disease (<a href="./references#CD003333-bbs2-0016" title="Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy ‐ I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81‐106. ">APT Collab I 1994</a>; <a href="./references#CD003333-bbs2-0017" title="Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy ‐ II:Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ1994;308:159‐68. ">APT Collab II 1994</a>; <a href="./references#CD003333-bbs2-0023" title="KlimtCR , KnatterudGL , StamlerJ , MeierP . Persantine‐Aspirin Reinfarction Study. Part II. Secondary coronary preventionwith persantine and aspirin. Journal of the American College of Cardiology1986;7:251‐69. ">Klimt 1986</a>). However, dipyridamole appears to have little antithrombotic effect, and studies have indicated that the addition of dipyridamole adds little to aspirin therapy alone in most cardiovascular diseases. In contrast, the newer platelet‐active agent clopidogrel has been studied in the large Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) trial, with evidence of a reduction in the composite outcome of vascular death, ischaemic stroke and myocardial infarction in patients with a history of cardiovascular disease (<a href="./references#CD003333-bbs2-0020" title="CAPRIE Steering Committee. A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet1996;348:1329‐39. ">CAPRIE 1996</a>).<br/> <br/> There have been few prospective studies of oral anticoagulants or antiplatelet agents in patients with heart failure in sinus rhythm. Given the evident prothrombotic state in such patients, it is plausible that use of oral anticoagulants can be beneficial. The previous version of this Cochrane review was not able to conclude that oral anticoagulation was better than antiplatelet therapy, but the analysis was limited by the paucity of high‐quality studies. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis in 2012, 'Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm', concluded that "[w]hilst there is the potential for a reduction in ischaemic stroke, there is currently no compelling reason to routinely use warfarin for these patients" (<a href="./references#CD003333-bbs2-0025" title="LipGY , PiotrponikowskiP , AndreottiF , AnkerSD , FilippatosG , HommaS , et al. Heart Failure Association (EHFA) of the European Society of Cardiology (ESC) and the ESC Working Group onThrombosis. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Thrombosis and Haemostasis2012;108:1009‐22. ">Lip 2012</a>). We performed a new literature search for this Cochrane review update to reflect recent advances in the field. </p> </section> <section id="CD003333-sec-0033"> <h3 class="title" id="CD003333-sec-0033">How the intervention might work</h3> <p>The efficacy of antithrombotic therapy in arterial fibrillation (including in people with heart failure) and of oral anticoagulation versus placebo for heart failure in sinus rhythm are the subjects of related Cochrane reviews (<a href="./references#CD003333-bbs2-0014" title="AguilarMI , HartR . Antiplatelet therapy for preventing stroke in patients with non‐valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD001925.pub2] ">Aguilar 2005</a>; <a href="./references#CD003333-bbs2-0026" title="LipGY , ShantsilaE . Anticoagulation versus placebo for heart failure in sinusrhythm. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD003336.pub3] ">Lip 2014</a>), and we will not address these topics in the present review, which focuses on heart failure with sinus rhythm.<br/> <br/> There is compelling evidence that aspirin reduces the short term risk of death after myocardial infarction, although the mortality benefits are less impressive during long‐term treatment or following the late initiation of aspirin (<a href="./references#CD003333-bbs2-0016" title="Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy ‐ I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81‐106. ">APT Collab I 1994</a>; <a href="./references#CD003333-bbs2-0018" title="Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta‐analysis of individual participant data from randomised trials. Lancet2009;373(9678):1849‐60. ">ATT 2009</a>). This evidence supports the use of aspirin in heart failure patients with ischaemic heart disease, although many of these patients have only a distant history of myocardial infarction, and the magnitude of any potential long‐term benefits is not conclusively established. </p> <p>Antithrombotic agents (i.e. oral anticoagulants or antiplatelet agents) might reduce thrombotic complications, such as myocardial infarction and stroke, and improve survival in heart failure with sinus rhythm. Bleeding complications are not uncommon with these agents, an important consideration during assessment of their overall benefits. </p> </section> <section id="CD003333-sec-0034"> <h3 class="title" id="CD003333-sec-0034">Why it is important to do this review</h3> <p>This review addresses an important problem, and it calls for the best evidence‐based antithrombotic therapy in heart failure without arterial fibrillation. The studies available at the time of the previous version of the review produced conflicting results. The new study included in this update contributes more participants for the analysis than the three older studies combined, thus significantly improving the power and validity of the analysis. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003333-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003333-sec-0035"></div> <p>To assess the effects of oral anticoagulant therapy versus antiplatelet agents for all‐cause mortality, non‐fatal cardiovascular events and risk of major bleeding in adults with heart failure (either with reduced or preserved ejection fraction) who are in sinus rhythm. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003333-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003333-sec-0036"></div> <section id="CD003333-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003333-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCT) comparing antiplatelet therapy with oral anticoagulation.</p> </section> <section id="CD003333-sec-0039"> <h4 class="title">Types of participants</h4> <p>People aged 16 years or older with clinically defined heart failure and if possible, with objective evidence of left ventricular systolic dysfunction, diastolic dysfunction (e.g. echocardiography, radionuclide ventriculography) or both. Patients with heart failure with reduced or preserved ejection fraction were eligible. We excluded studies in participants with arterial fibrillation only and studies that did not perform a separate analysis for a subgroup of participants with heart failure. </p> </section> <section id="CD003333-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Orally administered antiplatelet agents (aspirin, ticlopidine, clopidogrel, prasugrel, ticagrelor or dipyridamole) compared with oral anticoagulants (coumarins, warfarin, dabigatran, apixaban, edoxaban or rivaroxaban). We considered studies administering treatment for at least one month. We excluded studies with additional simultaneously tested active treatments in the intervention arm (e.g. beta‐blockers, angiotensin converting enzyme (ACE) inhibitors, etc.). </p> </section> <section id="CD003333-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD003333-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD003333-list-0001"> <li> <p>All‐cause mortality</p> </li> <li> <p>Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism) </p> </li> </ul> </p> </section> <section id="CD003333-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD003333-list-0002"> <li> <p>Major bleeding events</p> </li> </ul> </p> <p>We excluded studies without recorded or available clinical events.</p> </section> </section> </section> <section id="CD003333-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003333-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We updated the searches from 2005 (<a href="./appendices#CD003333-sec-0081">Appendix 1</a>) and re‐ran them in February 2010 (<a href="./appendices#CD003333-sec-0085">Appendix 2</a>), June 2013 (<a href="./appendices#CD003333-sec-0089">Appendix 3</a>) and September 2015 (<a href="./appendices#CD003333-sec-0093">Appendix 4</a>). </p> <p> <ul id="CD003333-list-0003"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) (2015, Issue 8) in <i>The Cochrane Library.</i> </p> </li> <li> <p>MEDLINE (Ovid, 1946 to September week 1 2015).</p> </li> <li> <p>Embase (Ovid, 1980 to 2015 week 37).</p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE) (Issue 1, 2010) in <i>The Cochrane Library</i> (not updated in 2015). </p> </li> </ul> </p> <p>We used the Cochrane sensitivity‐maximising RCT filters to search MEDLINE and Embase (<a href="./references#CD003333-bbs2-0024" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>), applying no language or date restrictions. We would have had relevant foreign language papers translated and we handsearched the reference lists of papers. </p> <p>We searched two clinical trials registers on 29 July 2016: ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.ClinicalTrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). See <a href="./appendices#CD003333-sec-0093">Appendix 4</a> for the search terms used. </p> </section> <section id="CD003333-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We searched abstracts from national and international cardiology meetings (American Heart Congress, American College of Cardiology Congress, European Society of Cardiology Congress, Congress of the International Society on Thrombosis and Haemostasis, European Stroke Conference, International Stroke Conference, World Stroke Congress, UK Stroke Forum Conference and the Heart Failure Congress) from 1980 (or the date the resource became available) to September 2015 to identify unpublished studies, and we contacted relevant authors of these studies to obtain further details, if required. </p> </section> </section> <section id="CD003333-sec-0047"> <h3 class="title" id="CD003333-sec-0047">Data collection and analysis</h3> <section id="CD003333-sec-0048"> <h4 class="title">Selection of studies</h4> <p>The authors (ES, GYHL) independently selected suitable trials for inclusion in the review, resolving disagreements by discussion. </p> </section> <section id="CD003333-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>The review authors (ES and GYHL) screened studies for inclusion and retrieved all potentially relevant studies. Later the authors independently reviewed characteristics of the preselected studies to identify studies eligible for this review. The authors were not blinded to any aspect of the studies (for example, journal type, authors' names, institution). There was no disagreement regarding the selection of eligible studies. Both authors extracted information on study populations, interventions, pre‐specified outcomes, methodology, and quality of the eligible trials. </p> </section> <section id="CD003333-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Using the guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003333-bbs2-0021" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), we assessed six domains related to risk of bias: randomisation sequence generation, allocation concealment, incomplete outcome data, selective reporting, blinding of participants and personnel, and blinding of outcome assessors. </p> </section> <section id="CD003333-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed dichotomous data on outcomes as Mantel‐Haenszel risk ratios (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD003333-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>For unpublished studies or where data were incomplete in published papers, we made attempts to contact authors or researchers to obtain further details. Where relevant, we contacted pharmaceutical companies to attempt to obtain unpublished trial data on newer antiplatelet drugs that may have been used in patients with heart failure. </p> </section> <section id="CD003333-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity appropriately in each meta‐analysis using the I<sup>2</sup> and Chi<sup>2</sup> statistics. We regarded heterogeneity as substantial if I<sup>2</sup> was greater than 50% or there was a low P value (less than 0.10) in the Chi<sup>2</sup> test for heterogeneity. </p> </section> <section id="CD003333-sec-0054"> <h4 class="title">Data synthesis</h4> <p>We considered whether an overall summary was meaningful and used a fixed‐effects model to conduct meta‐analysis. </p> </section> <section id="CD003333-sec-0055"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Heterogeneity was low across the included studies. If it were high, we would have investigated it through subgroup analyses. </p> </section> <section id="CD003333-sec-0056"> <h4 class="title">Sensitivity analysis</h4> <p>We would have conducted sensitivity analyses to explore the effect of trial quality for each comparison by restricting the analysis to those trials rated as being at low risk of bias for random sequence generation and allocation concealment. However, all included trials were of low risk of bias in these domains. </p> <section id="CD003333-sec-0057"> <h5 class="title">Summary of findings table</h5> <p>We created a 'Summary of findings' table using the following outcomes: all‐cause mortality, non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism), and major bleeding events. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence as it relates to the studies contributing data to the meta‐analyses for the prespecified outcomes. We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="https://archie.cochrane.org/sections/documents/view?version=z1505121641405496444876757172648%26format=REVMAN#REF-Higgins-2011" target="_blank">Higgins 2011</a>) using GRADEpro software. We justified all decisions to downgrade the quality of studies using footnotes, and we made comments to aid readers' understanding of the review where necessary. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003333-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003333-sec-0058"></div> <section id="CD003333-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD003333-sec-0060"> <h4 class="title">Results of the search</h4> <p>The initial search in 2005 yielded 1647 records, of which we excluded 1631 after screening titles and abstracts. We assessed the full text of the remaining 16 records. <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a> met our inclusion criteria. We excluded 12 studies, and the other 3 were ongoing (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>; <a href="./references#CD003333-bbs2-0036" title="PullicinoPM , HalperinJL , ThompsonJL . Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology2000;54(2):288‐94. ">WARCEF 2000</a>). </p> <p>The updated search in 2010 yielded 1219 new records, of which we excluded 1203 after screening the titles and abstracts. We assessed 16 full‐text records and included two previously ongoing studies (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>). </p> <p>The updated search in 2013 yielded 1460 new records, of which we excluded 1452 after screening the titles and abstracts. Four records were abstracts of interest based on two retrospective analyses. However, they did not specify the proportion of participants with atrial fibrillation and did not provide information on adverse outcomes, so we excluded them. We reviewed four full‐text records, one of which met the inclusion criteria (<a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>). </p> <p>The updated search in 2015 yielded 975 new records; we excluded 971 after screening the titles and abstracts and examined four records in detail. <a href="./references#CD003333-bbs2-0029" title="PullicinoPM , ThompsonJL , SaccoRL , SanfordAR , QianM , TeerlinkJR , et al. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial. Cerebrovascular Diseases2013;36:74‐8. ">Pullicino 2013</a> was a journal publication with a subanalysis of the <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a> study, looking at different types of stroke. The analysis did not add any new information relevant to this review. The three remaining records were abstracts of conference presentations of two small randomised studies (<a href="./references#CD003333-bbs2-0006" title="LiuPY , LiYH , ChenJH , TsaiLM , LiaoJK . A double‐blind randomized placebo pilot study comparing aggrenox versus placebo in heart failure patients (ASAP‐HF trial). European Journal of Heart Failure. 2013; Vol. 12:S74. ">ASAP‐HF 2013</a>; <a href="./references#CD003333-bbs2-0007" title="ParsonsS , RigbyAS , GittusC , McDonaghT , McMurrayJJ , SquireIB , et al. A randomized controlled trial of aspirin compared to clopidogrel in patients with heart failure. European Heart Journal2014;35:159. ParsonsS , RigbyAS , GittusC , McDonaghTA , McMurrayJJ , SquiteIB , et al. The clopidogrel or aspirin in chronic heart failure (CACHE) study. European Journal of Heart Failure2014;16:267‐8. ">CACHE‐EHF 2014</a>; CACHE‐EJHF 2014), which did not meet all inclusion criteria for this analysis. </p> <p>In total, this review includes four studies (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>; <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>). We present the reasons for excluding studies that closely missed the inclusion criteria in <a href="./references#CD003333-sec-0113" title="">Characteristics of excluded studies</a>. </p> <p>In the two clinical trials registers, we checked all the retrieved entries but found no additional studies meeting review requirements. </p> <p>We show the flow of studies, combined for all searches, in <a href="#CD003333-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD003333-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow chart." data-id="CD003333-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow chart.</p> </div> </div> </div> </section> <section id="CD003333-sec-0061"> <h4 class="title">Included studies</h4> <p>We included four RCTs that met the review criteria for assessing the effectiveness of antiplatelet therapy (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>; <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>; see <a href="./references#CD003333-sec-0112" title="">Characteristics of included studies</a>). </p> <p>All studies recruited patients with heart failure with reduced LVEF only. Arterial fibrillation was not an absolute exclusion criterion in <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>, but 92% of the study participants had no history of it at the time of recruitment. Other studies only included patients with sinus rhythm. The range of ages for the trials was 18 years and older with a mean age of 61 years across the trials. Most participants were men (61% to 93% across trials). We analysed all outcomes based on the intention‐to‐treat principle. </p> <p>The studies were international (involving the USA, the UK, countries in Western and Eastern Europe, Canada and Argentina). The pharmaceutical industry provided some funding and support to the studies. The WASH trial was partly supported by the Bristol‐Myers Squibb, which manufactures warfarin in the USA. The Bristol‐Myers Squibb, Sanofi‐Synthelabo, and Dupont pharmaceutical companies partly supported the WATCH trial through unrestricted grants and provision of the study drugs. <a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a> did not specify sources of funding, but Greece‐based centres led and coordinated the study, and Greece‐based companies manufactured all study agents. </p> <p><a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a> was a pilot study in 279 participants recruited from 17 centres in the UK and 3 centres in the USA. This review analysed only the 180 patients randomised to warfarin (target international normalised ratio (INR) 2.0 to 3.0) versus aspirin (300 mg once daily). The remaining patients were randomised to no antithrombotic therapy and thus were outside the scope of the analysis. Investigators recorded baseline data on all participants by telephone at the data centre before randomisation using prospectively constructed blocks of random numbers. </p> <p>Participants had to have a clinical diagnosis of heart failure requiring treatment with diuretics and evidence of left ventricular systolic dysfunction on echocardiography within six months before entry (<a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>). Echocardiographic criteria of left ventricular dysfunction included an increased left ventricular end‐diastolic internal dimension (≥ 56 mm or ≥ 30 mm/m<sup>2</sup> body surface area) combined with a fractional shortening of at least 28% or LVEF of at least 35%. Investigators were encouraged to use warfarin in participants who developed arterial fibrillation and to reduce the dose of aspirin or use any appropriate antidyspeptic medication if dyspepsia occurred. This trial was limited by open‐label treatment with warfarin, small numbers and relatively short follow‐up (27 ± 1 months). Also, from the study manuscript is not clear whether any patients had incomplete outcome data. </p> <p><a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a> recruited 197 participants in centres in Greece, Cyprus, Yugoslavia, Romania, Bulgaria, Poland and Georgia. We excluded the participants with dilated cardiomyopathy who were randomised to warfarin versus placebo, but we included participants with underlying ischaemic heart disease (n = 115) who were randomised to warfarin versus aspirin. The trial was double‐blinded and included participants with the New York Heart Association (NYHA) class II to IV and LVEF of more than 35% assessed by echocardiography, or by radionuclide or angiocardiographic ventriculography. The University coordination centre conducted computerised randomisation by fax or telephone.Investigators were blinded to therapy, and warfarin doses were recommended according to sham results where appropriate. However, the study manuscript does not provide details on the sham procedures, and it is unclear how robust they were. The participants were regularly followed up with a recording of any clinical outcomes. As with <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>, <a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a> is limited by the small number of participants and short follow‐up period (mean follow‐up time of 18.5 months for those taking aspirin and 18.7 months for those taking warfarin). It is not clear whether there was an independent assessment of study outcomes. </p> <p><a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a> included 1587 participants from 142 centres in the USA, Canada and the UK. Patients were eligible if they had NYHA class II to IV heart failure for more than three months, LVEF of less than 35%, were in sinus rhythm and on a diuretic and ACE inhibitor (unless not tolerated). Patients were randomised into three arms: aspirin 162 mg once daily, clopidogrel 75 mg once daily in a double‐blind, double‐dummy manner, or open label warfarin (target INR 2.5 to 3.0). The Cooperative Studies Program Coordinating Center (CSPCC) generated randomisation sequences for each site and allocated treatment. The main outcome measures were adjudicated by a blinded committee. The mean duration of follow‐up was 1.9 years, for a total of 3073 patient‐years of follow‐up. Due to slow enrolment, the study failed to recruit the pre‐specified target of 4500 participants. The study was limited by open‐label management of warfarin. Also, similar to <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>, , it is not clear whether any participants in <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a> had incomplete outcome data. </p> <p><a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a> was a large RCT conducted at 168 centres in 11 countries. The trial recruited 2305 participants with LVEF of 35% or less and sinus rhythm who were randomised to warfarin (target INR of 2.0 to 3.5) or aspirin (325 mg once daily). Investigators reported the primary outcomes of the first event in a composite endpoint of ischaemic stroke, intracerebral haemorrhage or death from any cause during a mean follow‐up period of of 3.5 ± 1.8 years. Two independent core echocardiography laboratories, which were unaware of the study treatment, assessed the accuracy of LVEF measurement. An independent endpoint adjudication committee blinded to the treatment assignments adjudicated all primary and secondary outcomes and cases of major haemorrhage. The WARCEF trial was a well‐designed, adequately powered study with low risk of the assessed bias types. </p> </section> <section id="CD003333-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded 40 references and present our reasons for excluding 9 studies that most closely missed the inclusion criteria in <a href="./references#CD003333-sec-0113" title="">Characteristics of excluded studies</a>. </p> <p>Four RCTs of ACE inhibitors assessed the use of antithrombotic therapy in participants with heart failure and/or left ventricular systolic dysfunction (<a href="./references#CD003333-bbs2-0005" title="Al‐KhadraAS , SalemDN , RandWM , UdelsonJE , SmithJJ , KonstamMA . Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. Journal of the American College of Cardiology1998;31:419‐25. ">Al‐Khadra 1998a</a>; <a href="./references#CD003333-bbs2-0010" title="LohE , SuttonMS , WunCC , RouleauJL , FlakerGC , GottliebSS , et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. New England Journal of Medicine1997;336:251‐7. ">SAVE 1997</a>; <a href="./references#CD003333-bbs2-0011" title="DriesDL , DomanskiMJ , WaclawiwMA , GershBJ . Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure. American Journal of Cardiology1997;79:909‐13. DriesDL , RosenbergYD , WaclawiwMA , DomanskiMJ . Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. Journal of the American College of Cardiology1997;29:1074‐80. ">SOLVD 1997</a>; <a href="./references#CD003333-bbs2-0012" title="DunkmanWB , JohnsonGR , CarsonPE , BhatG , FarrellL , CohnJN , for the V‐HeFT VA Cooperative Studies Group. Incidence of thromboembolic events in congestive heart failure. Circulation1993;87(Suppl 6):VI194‐VI101. ">V‐HeFT II 1992</a>). These analyses were done outside the randomisation scheme. <a href="./references#CD003333-bbs2-0012" title="DunkmanWB , JohnsonGR , CarsonPE , BhatG , FarrellL , CohnJN , for the V‐HeFT VA Cooperative Studies Group. Incidence of thromboembolic events in congestive heart failure. Circulation1993;87(Suppl 6):VI194‐VI101. ">V‐HeFT II 1992</a> included participants with symptomatic heart failure and radiological, echocardiographic or radionuclide evidence of left ventricular systolic dysfunction. The SOLVD trials included participants with left ventricular systolic dysfunction, defined as a LVEF of 35% or less, who were either symptomatic and enrolled into the treatment trial (<a href="./references#CD003333-bbs2-0032" title="The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine1991;325:293‐302. ">SOLVD‐treatment 1991</a>), or asymptomatic and enrolled into the prevention trial (<a href="./references#CD003333-bbs2-0031" title="The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine1992;327:685‐91. ">SOLVD‐prevent 1992</a>). <a href="./references#CD003333-bbs2-0010" title="LohE , SuttonMS , WunCC , RouleauJL , FlakerGC , GottliebSS , et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. New England Journal of Medicine1997;336:251‐7. ">SAVE 1997</a> included participants post‐myocardial infarction with an LVEF of 40% or more and no overt heart failure (i.e. asymptomatic participants). <a href="./references#CD003333-bbs2-0009" title="FalkRH , PollakA , TandonPK , PackerM . The effect of warfarin on prevalence of stroke in patients with severe heart failure. Journal of the American College of Cardiology1993;21(Suppl 2):218A. ">PROMISE 1993</a> presented limited information from a retrospective analysis of one trial in abstract form only. </p> <p>In one recent retrospective, observational, non‐randomised study, investigators used aspirin in 32% of 417 participants (warfarin in 28%) with an average follow‐up of five years (<a href="./references#CD003333-bbs2-0008" title="EchemannM , AllaF , BrianconS , JuilliereY , VirionJM , MertesPM , et al. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction severe heart failure and left ventricular systolic dysfunction (EPICAL study). European Journal of Heart Failure2002;4(5):647‐54. ">EPICAL 2002</a>). Treatment with antithrombotic agents (either aspirin, warfarin or both) was associated with better survival at five years (40.4% versus 31% with no antithrombotic treatment, P = 0.01). However, we excluded this study because 24% of the participants had concomitant arterial fibrillation, investigators reported only survival rates, and they did not report event rates separately for the sinus rhythm group or those treated was aspirin, warfarin or no therapy. </p> <p>Two almost identical abstracts presented results of the randomised open‐label clopidogrel versus aspirin in chronic heart failure (CACHE) study that compared 75 mg daily doses of the two drugs in 87 participants with heart failure in sinus rhythm and an N‐terminal‐pro‐brain natriuretic peptide (NT‐proBNP) of 400 ng/L (mostly NYHA II) (<a href="./references#CD003333-bbs2-0007" title="ParsonsS , RigbyAS , GittusC , McDonaghT , McMurrayJJ , SquireIB , et al. A randomized controlled trial of aspirin compared to clopidogrel in patients with heart failure. European Heart Journal2014;35:159. ParsonsS , RigbyAS , GittusC , McDonaghTA , McMurrayJJ , SquiteIB , et al. The clopidogrel or aspirin in chronic heart failure (CACHE) study. European Journal of Heart Failure2014;16:267‐8. ">CACHE‐EHF 2014</a>; CACHE‐EJHF 2014). By six months, treatment with aspirin was associated with worse renal function and higher diastolic blood pressure compared with clopidogrel, but investigators did not report any major adverse outcomes. The study did not have a comparator other than another antiplatelet agent (i.e. placebo or oral anticoagulant), so we excluded it from the analysis. </p> <p>No adequately powered prospective studies have specifically examined the role of the antiplatelet agent dipyridamole in heart failure participants. There was a small randomised pilot study of dipyridamole plus aspirin (aggrenox) versus placebo in 18 participants with congestive heart failure (NYHA class II to IV) and LVEF of less than 40%, presented as a conference abstract in 2013 (<a href="./references#CD003333-bbs2-0006" title="LiuPY , LiYH , ChenJH , TsaiLM , LiaoJK . A double‐blind randomized placebo pilot study comparing aggrenox versus placebo in heart failure patients (ASAP‐HF trial). European Journal of Heart Failure. 2013; Vol. 12:S74. ">ASAP‐HF 2013</a>). After six months of therapy, there were no reported changes in haemodynamic characteristics in either group. BNP levels were reduced in the treatment group, but not in the placebo group (the report did not include a between‐group comparison). More participants in the treatment group showed improvement in six‐minute walking distance than in the placebo group. We excluded the study because no clinical events were recorded (although investigators mentioned the absence of bleeding events in both groups). There were two active treatments in the intervention arms, and investigators provided no information on whether the participants were in arterial fibrillation or sinus rhythm. </p> <p>The ongoing <a href="./references#CD003333-bbs2-0013" title="NCT01877915 . A sStudy to assess the effectiveness and safety of rivaroxaban in reducing the risk of death, myocardial infarction or stroke in participants with heart failure and coronary artery disease following an episode of decompensated heart failure (COMMANDER HF) [A randomized, double‐blind, event‐driven, multicenter study comparing the efficacy and safety of rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an episode of decompensated heart failure]. clinicaltrials.gov/ct2/show/NCT01877915 (first received 12 June 2013). ">COMMANDER HF trial</a> (<a href="./references#CD003333-bbs2-0013" title="NCT01877915 . A sStudy to assess the effectiveness and safety of rivaroxaban in reducing the risk of death, myocardial infarction or stroke in participants with heart failure and coronary artery disease following an episode of decompensated heart failure (COMMANDER HF) [A randomized, double‐blind, event‐driven, multicenter study comparing the efficacy and safety of rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an episode of decompensated heart failure]. clinicaltrials.gov/ct2/show/NCT01877915 (first received 12 June 2013). ">COMMANDER HF trial</a>) compares rivaroxaban versusvs. placebo in participantpatients with heart failure of ischaemics aetiology with sinus rhythm. </p> </section> </section> <section id="CD003333-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>We summarize the 'Risk of bias' assessment in <a href="#CD003333-fig-0002">Figure 2</a> and <a href="#CD003333-fig-0003">Figure 3</a>. Because there were only four studies and all had a low risk of selection bias, we did not perform a sensitivity analysis. </p> <div class="figure" id="CD003333-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003333-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD003333-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003333-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD003333-sec-0064"> <h4 class="title">Allocation</h4> <p>All studies used central randomisation with low risk of bias in relation to random sequence generation and allocation concealment. </p> </section> <section id="CD003333-sec-0065"> <h4 class="title">Blinding</h4> <p>For blinding of participants and personnel, we assessed two studies as being at high risk (<a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>), one study as being at low risk (<a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>), and one study as being at unclear risk of blinding of participants and personnel (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>). </p> <p>We considered <a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a> to be at unclear risk of detection bias in relation to the blinding of outcome assessors, while the other three studies were at low risk (<a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>; <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>). </p> </section> <section id="CD003333-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>Two studies were also at unclear risk of incomplete outcome bias (<a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>), while two studies were at low risk of bias in this domain (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>). </p> </section> <section id="CD003333-sec-0067"> <h4 class="title">Selective reporting</h4> <p>We deemed all four included studies to be at low risk of selective reporting bias.</p> </section> </section> <section id="CD003333-sec-0068"> <h3 class="title" id="CD003333-sec-0068">Effects of interventions</h3> <p>See: <a href="./full#CD003333-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings: warfarin versus aspirin for heart failure with sinus rhythm</a>; <a href="./full#CD003333-tbl-0002"><b>Summary of findings 2</b> Summary of findings: warfarin versus clopidogrel for heart failure with sinus rhythm</a> </p> <section id="CD003333-sec-0069"> <h4 class="title">All‐cause mortality</h4> <p>Four trials involving 3663 participants reported all‐cause mortality for warfarin versus aspirin (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>; <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>). Participants in both groups were at a similar risk of all‐cause death (219 events per 1000 for both agents, Mantel‐Haenszel RR 1.00, 95% CI 0.89 to 1.13; I<sup>2</sup> = 0%; <a href="./references#CD003333-fig-0004" title="">Analysis 1.1</a>). The quality of the evidence was moderate. </p> <p><a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a> (N = 1064) reported on all‐cause mortality for warfarin versus clopidogrel, but there was no evidence that either treatment was superior to the other (RR 0.93, 95% CI 0.72 to 1.21; participants = 1064; low quality of evidence; <a href="./references#CD003333-fig-0007" title="">Analysis 2.1</a>). </p> </section> <section id="CD003333-sec-0070"> <h4 class="title">Non‐fatal cardiovascular events</h4> <p>Four trials with 3663 participants also reported non‐fatal cardiovascular events (such as non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism) for warfarin versus aspirin (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>; <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>). Treatment with warfarin was associated with a reduction in non‐fatal cardiovascular events (66 per 1000 for warfarin, 83 per 1000 for aspirin, Mantel‐Haenszel RR 0.79, 95% CI 0.63 to 1.00; I<sup>2</sup> = 0%; <a href="./references#CD003333-fig-0005" title="">Analysis 1.2</a>). The quality of the evidence was moderate. </p> <p><a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>) (N = 1064) reported non‐fatal cardiovascular events for warfarin versus clopidogrel. Patients in both groups were at similar risk (46 per 1000 for warfarin, 54 per 1000 for aspirin, Mantel‐Haenszel RR 0.85, 95% CI 0.50 to 1.45; <a href="./references#CD003333-fig-0008" title="">Analysis 2.2</a>). The quality of the evidence was low. </p> </section> <section id="CD003333-sec-0071"> <h4 class="title">Major bleeding events</h4> <p>Four trials (N = 3663) reported rates of major bleeding events (<a href="./references#CD003333-bbs2-0001" title="CokkinosDV , HaralabopoulosGC , KostisJB , ToutouzasPK . Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study. European Journal of Heart Failure2006;8:428‐2. ">HELAS 2006</a>; <a href="./references#CD003333-bbs2-0002" title="HommaS , ThompsonJL , PullicinoPM , LevinB , FreudenbergerRS , TeerlinkJR , et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. New England Journal of Medicine2012;366:1859‐69. ">WARCEF 2012</a>; <a href="./references#CD003333-bbs2-0003" title="ClelandJG , FindlayI , JafriS , et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. American Heart Journal2004;148:157‐64. ">WASH 2004</a>; <a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>). In the pooled analysis warfarin use was associated with a twofold increase in the risk of major bleeding compared to aspirin (56 per 1000 for warfarin, 28 per 1000 for aspirin, Mantel‐Haenszel RR 2.00, 95% CI 1.44 to 2.78; I<sup>2</sup> = 4%; <a href="./references#CD003333-fig-0006" title="">Analysis 1.3</a>). The quality of the evidence was moderate. </p> <p><a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a> (N = 1064) reported major bleeding events for warfarin versus clopidogrel. The rate of major bleeding events was 2.5 times higher in the warfarin group (49 per 1000 for warfarin, 20 per 1000 for aspirin, Mantel‐Haenszel RR 2.47, 95% CI 1.24 to 4.91; <a href="./references#CD003333-fig-0009" title="">Analysis 2.3</a>). The quality of the evidence was low. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003333-sec-0072" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003333-sec-0072"></div> <section id="CD003333-sec-0073"> <h3 class="title" id="CD003333-sec-0073">Summary of main results</h3> <p>The analysis of warfarin versus aspirin is based on four RCTs with a large overall number of participants. More than half of the participants were from the well‐designed, double‐blind WARCEF trial. Despite some limitations of other studies (e.g. open‐label treatment with warfarin in two trials), the analysis shows low heterogeneity of the outcomes, and we judged the quality of the evidence to be high for all‐cause mortality and moderate for non‐fatal cardiovascular events and major bleeding events. Despite the availability of different oral anticoagulants and antiplatelet agents, the main analysis is limited to the long‐established agents warfarin and aspirin. The analysis did not provide evidence that either was better for all‐cause mortality, and further studies are unlikely to change these conclusions. </p> <p>The risk of non‐fatal cardiovascular events tended to be lower in the warfarin group, but this was offset by the twofold rise in risk of major haemorrhage. The reduction in non‐fatal cardiovascular events is likely due to undiagnosed/silent arterial fibrillation and deep vein thrombosis in some patients. Again, further research of these two agents is unlikely to prove the clinical superiority of either. </p> <p>Comparison of warfarin with clopidogrel was limited to a single trial with open‐label warfarin management (<a href="./references#CD003333-bbs2-0004" title="MassieBM , CollinsJF , AmmonSE , ArmstrongPW , ClelandJGF , EzekowitzM , et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial. Circulation2009;119:1616‐24. ">WATCH 2009</a>). Slow recruitment restricted the statistical power, and as a result the trial was stopped early. The quality of the evidence for these analyses was low. However, the outcomes of these analyses were broadly similar to those of warfarin versus aspirin, with results that did not favour either drug for the primary outcome, but with 2.5 times higher major bleeding rates in the warfarin arm of the study. Further trials are unlikely to add more to the conclusions in relation to role of warfarin versus clopidogrel in heart failure in sinus rhythm. </p> </section> <section id="CD003333-sec-0074"> <h3 class="title" id="CD003333-sec-0074">Overall completeness and applicability of evidence</h3> <p>Non‐vitamin K antagonist oral anticoagulants (e.g. direct thrombin inhibitor, dabigatran, and factor Xa inhibitors, apixaban, edoxaban and rivaroxaban) have now been approved for clinical use in patients with arterial fibrillation and venous thromboembolism. These agents show good efficacy and a favourable safety profile and may become a suitable alternative to warfarin to be tested in future trials in heart failure with sinus rhythm. No such data are available at present. The ongoing <a href="./references#CD003333-bbs2-0013" title="NCT01877915 . A sStudy to assess the effectiveness and safety of rivaroxaban in reducing the risk of death, myocardial infarction or stroke in participants with heart failure and coronary artery disease following an episode of decompensated heart failure (COMMANDER HF) [A randomized, double‐blind, event‐driven, multicenter study comparing the efficacy and safety of rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an episode of decompensated heart failure]. clinicaltrials.gov/ct2/show/NCT01877915 (first received 12 June 2013). ">COMMANDER HF trial</a> compares rivaroxaban versus placebo in participants with heart failure of ischaemic aetiology with sinus rhythm. The non‐vitamin K antagonist oral anticoagulants are used as fixed‐dose agents as opposed to warfarin, and this would facilitate easier concealment of the study treatments. </p> <p>Given the fact that all four included RCTs focused on heart failure with reduced ejection fraction, it is not possible to extrapolate their conclusions to patients with heart failure with preserved ejection fraction. Admittedly, the specific prothrombotic risk in heart failure with preserved ejection fraction and sinus rhythm has not been firmly established, and further research would be essential in this field. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003333-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow chart." data-id="CD003333-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow chart.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003333-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003333-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Warfarin vs aspirin in heart failure with sinus rhythm, Outcome 1 All‐cause mortality." data-id="CD003333-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Warfarin vs aspirin in heart failure with sinus rhythm, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Warfarin vs aspirin in heart failure with sinus rhythm, Outcome 2 Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)." data-id="CD003333-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Warfarin vs aspirin in heart failure with sinus rhythm, Outcome 2 Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Warfarin vs aspirin in heart failure with sinus rhythm, Outcome 3 Major bleeding events." data-id="CD003333-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Warfarin vs aspirin in heart failure with sinus rhythm, Outcome 3 Major bleeding events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Warfarin vs clopidogrel in heart failure with sinus rhythm, Outcome 1 All‐cause mortality." data-id="CD003333-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Warfarin vs clopidogrel in heart failure with sinus rhythm, Outcome 1 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Warfarin vs clopidogrel in heart failure with sinus rhythm, Outcome 2 Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)." data-id="CD003333-fig-0008" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Warfarin vs clopidogrel in heart failure with sinus rhythm, Outcome 2 Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003333-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/urn:x-wiley:14651858:media:CD003333:CD003333-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_t/tCD003333-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Warfarin vs clopidogrel in heart failure with sinus rhythm, Outcome 3 Major bleeding events." data-id="CD003333-fig-0009" src="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Warfarin vs clopidogrel in heart failure with sinus rhythm, Outcome 3 Major bleeding events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/media/CDSR/CD003333/image_n/nCD003333-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003333-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: warfarin versus aspirin for heart failure with sinus rhythm</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Warfarin versus aspirin for heart failure with sinus rhythm</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: patients with heart failure with sinus rhythm </p> <p><b>Settings</b>: outpatient clinics </p> <p><b>Intervention</b>: warfarin </p> <p><b>Comparison</b>: aspirin </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)<sup>a</sup> </b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Aspirin</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Warfarin</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Mean follow‐up: 18.5‐42 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b><br/> (195 to 247) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> (0.89 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3663<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)</b> </p> <p>Mean follow‐up: 18.5‐42 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>66 per 1000</b><br/> (52 to 83) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.79</b> (0.63 to 1.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3663<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major bleeding events</b> </p> <p>Mean follow‐up: 18.5‐42 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b><br/> (40 to 78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.00</b> (1.44 to 2.78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3663<br/> (4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>b</sup><br/> <b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>All results are presented for the whole population analyses. The assumed risk is provided based on the aspirin group as aspirin is often used in patients with heart failure with sinus rhythm due to background ischaemic heart disease.<br/> <sup>b</sup>Downgraded due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: warfarin versus aspirin for heart failure with sinus rhythm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003333-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: warfarin versus clopidogrel for heart failure with sinus rhythm</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Warfarin versus clopidogrel for heart failure with sinus rhythm</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: patients with heart failure with sinus rhythm </p> <p><b>Settings</b>: oupatient clinics </p> <p><b>Intervention</b>: warfarin </p> <p><b>Comparison</b>: clopidogrel </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Clopidogrel</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Warfarin</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Mean follow‐up: 1.9 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>183 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>170 per 1000</b><br/> (132 to 221) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.93</b> (0.72 to 1.21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1064<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)</b> </p> <p>Mean follow‐up: 1.9 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b><br/> (27 to 78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b> (0.50 to 1.45) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1064<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major bleeding events</b> </p> <p>Mean follow‐up: 1.9 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b><br/> (25 to 98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.47</b> (1.24 to 4.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1064<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>RR</b>: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by two due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: warfarin versus clopidogrel for heart failure with sinus rhythm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/full#CD003333-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003333-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Warfarin vs aspirin in heart failure with sinus rhythm</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3663</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.89, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3663</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.63, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Major bleeding events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3663</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.44, 2.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Warfarin vs aspirin in heart failure with sinus rhythm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003333-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Warfarin vs clopidogrel in heart failure with sinus rhythm</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.72, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Non‐fatal cardiovascular events (non‐fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.50, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Major bleeding events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.47 [1.24, 4.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Warfarin vs clopidogrel in heart failure with sinus rhythm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003333.pub3/references#CD003333-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003333.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003333-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003333-note-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003333-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD003333-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ko#CD003333-note-0002">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD003333-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD003333-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD003333-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD003333-note-0013">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003333\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003333\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003333\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003333\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003333\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xx9QLps0&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003333.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003333.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003333.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003333.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003333.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715487016"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003333.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715487020"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003333.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d88493dd69374',t:'MTc0MDcxNTQ4Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 